fingolimod hydrochloride has been researched along with Lung Adenocarcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hazarosova, R; Krastev, N; Krastev, P; Momchilova, A; Nikolova, B; Pankov, R; Pankov, S; Pinkas, A; Robev, B; Staneva, G; Vassileva, E | 1 |
1 other study(ies) available for fingolimod hydrochloride and Lung Adenocarcinoma
| Article | Year |
|---|---|
Resveratrol Affects Sphingolipid Metabolism in A549 Lung Adenocarcinoma Cells.
Topics: A549 Cells; Adenocarcinoma of Lung; Alkaline Ceramidase; Antioxidants; Biochemical Phenomena; Ceramides; Fingolimod Hydrochloride; Humans; Lysophospholipids; Neuroprotective Agents; Polyphenols; Resveratrol; Sphingolipids; Sphingomyelin Phosphodiesterase; Sphingomyelins; Sphingosine | 2022 |